The eye muscles of humans with either inherited or sporadic forms of ALS are relatively unaffected during disease progression, a function of sparing of the cranial nerve motor neurons supplying them. Here we observe that cranial nerve nuclei are also spared in a mouse model of inherited SOD1-linked ALS. We examined the cranial nerve motor nuclei in a mouse strain, G85R SOD1YFP, which carries a high copy transgene encoding a mutant human SOD1-YFP fusion protein, that exhibits florid YFP-fluorescent aggregates in spinal cord motor neurons and paralyzes by 6 months of age. We observed in the cranial nerve nuclei that innervate the eye, 3N (oculomotor), 4N (trochlear), and 6N (abducens), that there was little (4N, 6N) or no (3N) aggregation, in comparison with other motor nuclei, 5N (trigeminal), 7N (facial), and 12N (hypoglossal), in the latter two of which florid aggregation was observed. Correspondingly, the number of ChAT positive motor neurons in 3N of G85R SOD1YFP relative to that in 3N of ChAT-EGFP mice showed that there was no loss of motor neurons over time, whereas in 12N there was progressive loss of motor neurons, amounting to a loss of ~30% from G85R SOD1YFP by end-stage. Thus, the sparing of extraocular motor neurons as occurs in humans with ALS appears to be replicated in our SOD1-linked ALS mouse strain, supporting the validity of the mouse model for studying this aspect of selective motor system loss in ALS. Comparisons of extraocular motor neurons (e.g., from 3N), resistant to ALS pathology, with other cranial motor neurons (e.g., from 12N), sensitive to such pathology, may thus be of value in understanding mechanisms of protection vs. susceptibility of motor neurons.
2

Summary.
The eye muscles of humans with either inherited or sporadic forms of ALS are relatively unaffected during disease progression, a function of sparing of the cranial nerve motor neurons supplying them. Here we observe that cranial nerve nuclei are also spared in a mouse model of inherited SOD1-linked ALS. We examined the cranial nerve motor nuclei in a mouse strain, G85R SOD1YFP, which carries a high copy transgene encoding a mutant human SOD1-YFP fusion protein, that exhibits florid YFP-fluorescent aggregates in spinal cord motor neurons and paralyzes by 6 months of age. We observed in the cranial nerve nuclei that innervate the eye, 3N (oculomotor), 4N (trochlear), and 6N (abducens), that there was little (4N, 6N) or no (3N) aggregation, in comparison with other motor nuclei, 5N
(trigeminal), 7N (facial), and 12N (hypoglossal), in the latter two of which florid aggregation was observed. Correspondingly, the number of ChAT positive motor neurons in 3N of G85R SOD1YFP relative to that in 3N of ChAT-EGFP mice showed that there was no loss of motor neurons over time, whereas in 12N there was progressive loss of motor neurons, amounting to a loss of ~30% from G85R SOD1YFP by end-stage. Thus, the sparing of extraocular motor neurons as occurs in humans with ALS appears to be replicated in our SOD1-linked ALS mouse strain, supporting the validity of the mouse model for studying this aspect of selective motor system loss in ALS. Comparisons of extraocular motor neurons (e.g., from 3N), resistant to ALS pathology, with other cranial motor neurons (e.g., from 12N), sensitive to such pathology, may thus be of value in understanding mechanisms of protection vs. susceptibility of motor neurons.
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The sparing of eye movements in ALS patients is well-known and has been related to lack of involvement of the motor nuclei innervating the extraocular muscles, namely, cranial nerve nuclei 3N (oculomotor), 4N (trochlear), and 6N (abducens) (ref.1 and references therein). We asked whether our mouse model of ALS, bearing a high copy number transgene of a human genomic clone of G85R mutant SOD1 (including the human promoter) fused in its last exon with YFP (2,3), might likewise exhibit sparing of the same cranial nerve motor nuclei as compared with the other cranial motor nuclei. Notably, spinal cord motor neurons in our mouse strain exhibit large YFP fluorescent aggregates by 1 month of age, which increase in number subsequently and are associated with motor neuron cell death, amounting to 50% loss by 3 months of age and 75% loss by end-stage (3). The mice exhibit lower extremity symptoms by 3 months of age -twitching or pulling in when picked up by the tail -and uniformly paralyze by 6 months of age (4). We thus examined the cranial nerve nuclei at these two times, in each case examining 3 mice. At both 3 months and 6 months (end-stage), we observed no aggregation in ChAT positive motor neurons in 3N (see representative images in Fig.1A and 1B, and quantitation in bar graphs below and Table 1 ). In particular, 3N exhibited no aggregates in greater than 500 ChAT-positive motor neurons examined, ~200 examined from three mice at 3 months and ~300 examined from three mice at end-stage. The two other extraocular nuclei, 4N and 6N, exhibited rare aggregates at 3 months of age and essentially none at end-stage (see Fig.1 bar graphs and Table 1 ). By contrast, 7N and 12N exhibited florid aggregation at both times (Fig.1A , 1B, and Table 1 ), affecting ~20-30% of neurons, whereas 5N was less affected, exhibiting a level of aggregation resembling that of 4N and 6N at 3 months, but greater than 3N, 4N, and 6N at end-stage.
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To inspect for whether ChAT-positive motor neuron survival was related to aggregation, we compared 3N and 12N from ChAT promoter-EGFP mice (using GFP fluorescence) with G85R SOD1YFP mice (using immunostaining with anti-ChAT) at 3 months and end-stage, counting motor neurons in 20 micron coronal sections taken at 100 micron intervals down the length of these nuclei, totaling 5 sections for 3N and 10 sections for 12N (see images in 2A and 2B for representative sections). The total of ChAT-positive motor neurons was then determined for each of 3 animals from the three groups. As shown in the bar graphs of Fig.2A , comparing ChAT-EGFP with G85R SOD1YFP 3 mo and endstage, the number of motor neurons in 3N was indistinguishable (the means were 297, 290, 327, nonsignificant p values with t-test). The lack of motor neuron loss in 3N thus mirrors the lack of aggregation. By contrast, the mean motor neuron count for 12N was reduced significantly in end-stage G85R SOD1YFP relative to ChAT-EGFP (507 vs. 708, p = 0.01). Thus for 12N, the occurrence of substantial aggregation was associated with significant cell loss, amounting to ~30%.
In sum, the foregoing data indicate that the cranial nerves supplying extraocular muscles in our SOD1-linked ALS mice are spared of aggregation relative to the other cranial motor nuclei, and where motor neuron survival was scored, there was no cell loss in 3N (oculomotor) vs. significant cell loss in 12N (hypoglossal) by end-stage. Thus, there appears to be a relationship between aggregation and cell loss, albeit it remains to be seen whether the former can drive the latter. It may rather be that the same cellular pathophysiology that drives aggregation can, at the same time, direct cell death. Regardless, the difference in behavior between 3N and 12N can serve as a basis for trying to understand mechanism(s) of protection/sensitivity. We presume that ultimately other mouse models of ALS will likely 5 exhibit the same extraocular motor sparing and that, more generally, at least some of the features of motor collapse in SOD1-linked ALS mice can serve to provide understanding of "sporadic" versions of ALS where, potentially, at least some similar steps of motor neuron loss are occurring. Aggregates were counted in 20 micron coronal sections from 3 mice at 3 months and 3 mice at end-stage. The neuron counts used to generate the bar graphs are shown in Table 1 . 
